Literature DB >> 331875

Effect of fusaric acid on tardive dyskinesia and mental state in psychogeriatric patients. A pilot study.

M Viukari, M Linnoila.   

Abstract

The effect of fusaric acid 150-450 mg daily on tardive dyskinesia and mental state was studied in 15 chronic psychogeriatric patients. The patient's previous drug treatment was maintained unchanged during the experiment. Fusaric acid significantly relieved oro-facial dyskinesia, tremor, and rigidity, and it improved the mental state of the patients (BPRS). Akathisia was exacerbated, but this change was not significant. Akinesia and anxiety were not altered.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 331875     DOI: 10.1111/j.1600-0447.1977.tb06663.x

Source DB:  PubMed          Journal:  Acta Psychiatr Scand        ISSN: 0001-690X            Impact factor:   6.392


  3 in total

1.  Serum neuroleptic concentrations and tardive dyskinesia.

Authors:  D V Jeste; M Linnoila; R L Wagner; R J Wyatt
Journal:  Psychopharmacology (Berl)       Date:  1982       Impact factor: 4.530

2.  Fusaric acid induces hepatic global m6A RNA methylation and differential expression of m6A regulatory genes in vivo - a pilot study.

Authors:  Terisha Ghazi; Savania Nagiah; Anil A Chuturgoon
Journal:  Epigenetics       Date:  2021-09-13       Impact factor: 4.861

Review 3.  Management of tardive dyskinesia: current update.

Authors:  G M Simpson; E H Pi; J J Sramek
Journal:  Drugs       Date:  1982-05       Impact factor: 9.546

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.